2021
DOI: 10.1111/ner.13469
|View full text |Cite
|
Sign up to set email alerts
|

First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 41 publications
0
1
0
Order By: Relevance
“…No relevant hypotensive effects were recorded 14. In a further step, doses of bupivacaine were increased, while morphine doses were decreased 15. This intervention did not alter the neurological deficit that was already established.…”
Section: Discussionmentioning
confidence: 98%
“…No relevant hypotensive effects were recorded 14. In a further step, doses of bupivacaine were increased, while morphine doses were decreased 15. This intervention did not alter the neurological deficit that was already established.…”
Section: Discussionmentioning
confidence: 98%